ɬÀï·¬

Composed of proteins, fibers, cells and other substances, attach, stabilize and reinforce the structure of human bodies. While there are many causes of connective tissue disorders, , or EDS, involves the disruption of collagen or collagen-regulating proteins by means of genetic mutations.

EDS, , is an inherited disorder that weakens connective tissues, specifically affecting the skin, joints and blood vessels. Researchers recently have found that some EDS-presenting families share mutations in the adipocyte enhancer binding protein 1, or AEBP1, gene, which encodes for the aortic carboxypeptidase-like protein, or ACLP, found in collagen-rich connective tissues including the skin, ligaments, tendons and vasculature. Individuals with AEBP1 mutations develop a subtype of EDS called EDS-classic-like-2, or EDSCLL2, which is characterized by joint hypermobility, abnormal scarring, delayed wound healing and vascular ruptures.

Medical student Neya Vishwanath, then a second-year master’s student in the medical sciences program at the , and colleagues in ’s lab were interested in investigating mutations in AEBP1 and the processing mechanisms for ACLP. Their goal was to examine mechanisms of protein secretion and collagen fiber stability for these proteins in the context of EDS.

“In all my biology courses, we were always taught how integral connective tissue is to a healthy body,” Vishwanath said. “In the Layne lab, (we) wanted to better understand the importance of ACLP in connective tissue health and figure out how mutations in ACLP could cause human disease.”

Layne Lab/JBC

This image shows 3T3 fibroblast cells transfected with wild-type aortic carboxypeptidase-like protein or tagged ACLP-Ins40. The mutated
protein leads to an apparent gap around the nucleus, potentially indicating an absence of intracellular trafficking to the Golgi.

In a in the Journal of Biological Chemistry, Vishwanath and colleagues highlight a specific mutation found in EDS patients called ACLP-Ins40. They found that this mutation, which causes an insertion of 40 amino acids in the collagen-binding region of ACLP, results in the improper exit of ACLP from cells and leads to cellular stress. The researchers also mapped and identified the specific amino acids required for proper ACLP secretion.

The team also identified novel protein processing mechanisms critical in ACLP secretion. Specifically, they demonstrated how glycosylation, or the addition of sugar groups to ACLP, is necessary for the proper cellular exit. When sugar groups are unattached to ACLP, the result is in-cell retention of ACLP and increased cellular stress.

Research with two other labs focused on the potential for ACLP to contribute to collagen fiber mechanics, specifically highlighting ACLP’s role in mechanical strength, Vishwanath said. “Our collaborative studies with Michael Smith and Joyce Wong’s laboratories at Boston University determined that ACLP contributes to the mechanical strength of collagen fibers that make up numerous connective tissues including ligaments, tendons, and cartilage.”

Vishwanath and her colleagues hope insights from this work will contribute to a greater understanding of the mechanisms involved in connective tissue structures and provide scientists with targets for pharmacological interventions to treat connective tissue disorders such as EDS.